Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > JSPR Jasper Therapeutics > Detailed Quotes

JSPR Jasper Therapeutics

Watchlist
1.930
+0.150+8.43%
Close  02/03 16:00 ET
1.930
-0.000-0.02%
Post Mkt Price 02/03 19:59 ET
High
2.020
Open
1.780
Turnover
4.88M
Low
1.730
Pre Close
1.780
Volume
2.55M
Market Cap
210.99M
P/E(TTM)
Loss
52wk High
5.390
Shares
109.32M
P/E(Static)
Loss
52wk Low
0.386
Float Cap
135.25M
Bid/Ask %
-63.64%
Historical High
18.880
Shs Float
70.08M
Volume Ratio
1.85
Historical Low
0.386
Dividend TTM
--
Div Yield TTM
--
P/B
4.44
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.64%
Amplitude
16.29%
Avg Price
1.910
Lot Size
1
Float Cap
135.25M
Bid/Ask %
-63.64%
Historical High
18.880
Shs Float
70.08M
Volume Ratio
1.85
Historical Low
0.386
Dividend TTM
--
P/B
4.44
Dividend LFY
--
Turnover Ratio
3.64%
Amplitude
16.29%
Avg Price
1.910
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
CEO: Mr. Ronald A. Martell
Market: NASDAQ
Listing Date: 01/10/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist